-
4
-
-
39049170984
-
Global strategy for asthma management and prevention: GINA executive summary
-
Jan
-
Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008 Jan; 31 (1): 143-78
-
(2008)
Eur Respir J
, vol.31
, Issue.1
, pp. 143-178
-
-
Bateman, E.D.1
Hurd, S.S.2
Barnes, P.J.3
-
5
-
-
0034642066
-
Long-term effects of budesonide or nedocromil in children with asthma
-
The Childhood Asthma Management Program Research Group Oct 12
-
The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000 Oct 12; 343 (15): 1054-63
-
(2000)
N Engl J Med
, vol.343
, Issue.15
, pp. 1054-1063
-
-
-
6
-
-
0034642055
-
Effect of long-term treatment with inhaled budesonide on adult height in children with asthma
-
Oct 12
-
Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000 Oct 12; 343 (15): 1064-9
-
(2000)
N Engl J Med
, vol.343
, Issue.15
, pp. 1064-1069
-
-
Agertoft, L.1
Pedersen, S.2
-
7
-
-
64149130397
-
Long-termbudesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents
-
May
-
Strunk RC, Sternberg AL, Szefler SJ, et al. Long-termbudesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents. J Pediatr 2009May; 154 (5): 682-7
-
(2009)
J Pediatr
, vol.154
, Issue.5
, pp. 682-687
-
-
Strunk, R.C.1
Sternberg, A.L.2
Szefler, S.J.3
-
8
-
-
48249098293
-
Effect of long-term corticosteroid use on bonemineral density in children: A prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study
-
Jul
-
Kelly HW, Van Natta ML, Covar RA, et al. Effect of long-term corticosteroid use on bonemineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study. Pediatrics 2008 Jul; 122 (1): e53-61
-
(2008)
Pediatrics
, vol.122
, Issue.1
-
-
Kelly, H.W.1
Van Natta, M.L.2
Covar, R.A.3
-
9
-
-
33846032661
-
Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial
-
Jan
-
Sorkness CA, Lemanske Jr RF, Mauger DT, et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2007 Jan; 119 (1): 64-72
-
(2007)
J Allergy Clin Immunol
, vol.119
, Issue.1
, pp. 64-72
-
-
Sorkness, C.A.1
Lemanske Jr., R.F.2
Mauger, D.T.3
-
10
-
-
33749185890
-
Treatment with 400 microg of inhaled budesonide versus 200 microg of inhaled budesonide and oral montelukast in children with moderate persistent asthma: Randomized controlled trial
-
Sep
-
Jat GC, Mathew JL, Singh M. Treatment with 400 microg of inhaled budesonide versus 200 microg of inhaled budesonide and oral montelukast in children with moderate persistent asthma: randomized controlled trial. Ann Allergy Asthma Immunol 2006 Sep; 97 (3): 397-401
-
(2006)
Ann Allergy Asthma Immunol
, vol.97
, Issue.3
, pp. 397-401
-
-
Jat, G.C.1
Mathew, J.L.2
Singh, M.3
-
11
-
-
43949129790
-
Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: A systematic review
-
May
-
Joos S, Miksch A, Szecsenyi J, et al. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review. Thorax 2008 May; 63 (5): 453-62
-
(2008)
Thorax
, vol.63
, Issue.5
, pp. 453-462
-
-
Joos, S.1
Miksch, A.2
Szecsenyi, J.3
-
12
-
-
1842370350
-
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group
-
Nov 13
-
Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997 Nov 13; 337 (20): 1405-11
-
(1997)
N Engl J Med
, vol.337
, Issue.20
, pp. 1405-1411
-
-
Pauwels, R.A.1
Lofdahl, C.G.2
Postma, D.S.3
-
13
-
-
5144221336
-
Can guideline-defined asthma control be achieved? the Gaining Optimal Asthma Control study
-
Oct 15
-
Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Am J Respir Crit Care Med 2004 Oct 15; 170 (8): 836-44
-
(2004)
Am J Respir Crit Care Med
, vol.170
, Issue.8
, pp. 836-844
-
-
Bateman, E.D.1
Boushey, H.A.2
Bousquet, J.3
-
14
-
-
68149179757
-
Salmeterol/fluticasone propionate versus double dose fluticasone propionate on lung function and asthma control in children
-
Dec
-
de Blic J, Ogorodova L, Klink R, et al. Salmeterol/fluticasone propionate versus double dose fluticasone propionate on lung function and asthma control in children. Pediatr Allergy Immunol 2009 Dec; 20 (8): 763-71
-
(2009)
Pediatr Allergy Immunol
, vol.20
, Issue.8
, pp. 763-771
-
-
De Blic, J.1
Ogorodova, L.2
Klink, R.3
-
15
-
-
0029758728
-
Salmeterol versus formoterol in patients with moderately severe asthma: Onset and duration of action
-
van Noord JA, Smeets JJ, Raaijmakers JA, et al. Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action. Eur Respir J 1996; 9 (8): 1684-8
-
(1996)
Eur Respir J
, vol.9
, Issue.8
, pp. 1684-1688
-
-
Van Noord, J.A.1
Smeets, J.J.2
Raaijmakers, J.A.3
-
16
-
-
12144270425
-
Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma
-
Jan 15
-
OByrne PM, Bisgaard H, Godard PP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005 Jan 15; 171 (2): 129-36
-
(2005)
Am J Respir Crit Care Med
, vol.171
, Issue.2
, pp. 129-136
-
-
Obyrne, P.M.1
Bisgaard, H.2
Godard, P.P.3
-
17
-
-
33845928663
-
Budesonide/formoterol maintenance plus reliever therapy: A new strategy in pediatric asthma
-
Dec
-
Bisgaard H, Le RP, Bjamer D, et al. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest 2006 Dec; 130 (6): 1733-43
-
(2006)
Chest
, vol.130
, Issue.6
, pp. 1733-1743
-
-
Bisgaard, H.1
Le Bjamer, R.P.D.2
-
18
-
-
44949194776
-
Regular treatment with salmeterol for chronic asthma: Serious adverse events
-
Cates CJ, Cates MJ. Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev 2008; (3): CD006363
-
(2008)
Cochrane Database Syst Rev
, Issue.3
-
-
Cates, C.J.1
Cates, M.J.2
-
19
-
-
44949194776
-
Regular treatment with formoterol for chronic asthma: Serious adverse events
-
Cates CJ, Cates MJ, Lasserson TJ. Regular treatment with formoterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev 2008; (4): CD006923
-
(2008)
Cochrane Database Syst Rev
, Issue.4
-
-
Cates, C.J.1
Cates, M.J.2
Lasserson, T.J.3
-
20
-
-
70049106524
-
Regular treatment with formoterol and inhaled steroids for chronic asthma: Serious adverse events
-
Cates CJ, Lasserson TJ, Jaeschke R. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev 2009; (2): CD006924
-
(2009)
Cochrane Database Syst Rev
, Issue.2
-
-
Cates, C.J.1
Lasserson, T.J.2
Jaeschke, R.3
-
21
-
-
70049106524
-
Regular treatment with salmeterol and inhaled steroids for chronic asthma: Serious adverse events
-
Cates CJ, Lasserson TJ, Jaeschke R. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev 2009; (3): CD006922
-
(2009)
Cochrane Database Syst Rev
, Issue.3
-
-
Cates, C.J.1
Lasserson, T.J.2
Jaeschke, R.3
-
22
-
-
77949576423
-
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids
-
Lemanske Jr RF, Mauger DT, Sorkness CA, et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med 2010; 362 (11): 975-85
-
(2010)
N Engl J Med
, vol.362
, Issue.11
, pp. 975-985
-
-
Lemanske Jr., R.F.1
Mauger, D.T.2
Sorkness, C.A.3
-
23
-
-
18144383000
-
Short-term lower-leg growth rate and urine cortisol excretion in children treated with ciclesonide
-
May
-
Agertoft L, Pedersen S. Short-term lower-leg growth rate and urine cortisol excretion in children treated with ciclesonide. J Allergy Clin Immunol 2005 May; 115 (5): 940-5
-
(2005)
J Allergy Clin Immunol
, vol.115
, Issue.5
, pp. 940-945
-
-
Agertoft, L.1
Pedersen, S.2
-
24
-
-
77954142714
-
Lower-leg growth rates in children with asthma during treatment with ciclesonide and fluticasone propionate
-
Feb
-
Agertoft L, Pedersen S. Lower-leg growth rates in children with asthma during treatment with ciclesonide and fluticasone propionate. Pediatr Allergy Immunol 2010 Feb; 21 (1 Pt II): e199-205
-
(2010)
Pediatr Allergy Immunol
, vol.21
, Issue.1 PART 2
-
-
Agertoft, L.1
Pedersen, S.2
-
25
-
-
34447116988
-
Comparison of the efficacy and safety of ciclesonide 160 microg once daily versus budesonide 400 microg once daily in children with asthma
-
Aug
-
von Berg A, Engelstatter R, Minic P, et al. Comparison of the efficacy and safety of ciclesonide 160 microg once daily versus budesonide 400 microg once daily in children with asthma. Pediatr Allergy Immunol 2007 Aug; 18 (5): 391-400
-
(2007)
Pediatr Allergy Immunol
, vol.18
, Issue.5
, pp. 391-400
-
-
Von Berg, A.1
Engelstatter, R.2
Minic, P.3
-
26
-
-
33749565533
-
A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma
-
Oct
-
Pedersen S, Garcia Garcia ML, Manjra A, et al. A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma. Pediatr Pulmonol 2006 Oct; 41 (10): 954-61
-
(2006)
Pediatr Pulmonol
, vol.41
, Issue.10
, pp. 954-961
-
-
Pedersen, S.1
Garcia Garcia, M.L.2
Manjra, A.3
|